Evidence map›Paper›PMID 42352894›Full record

ArticleInternational journal of molecular sciences2026

Exploring Mechanistic Targets of

Sakawrat Janpaijit, Kanika Verma, Ansella Amanda Epifani Widoyanti, Tewin Tencomnao, Anchalee Prasansuklab

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sakawrat JanpaijitCollege of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Kanika VermaDepartment of Molecular Epidemiology, ICMR-National Institute of Malaria Research, New Delhi 110077, India.
Ansella Amanda Epifani WidoyantiCollege of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0009-0009-9079-2219
Tewin TencomnaoCenter of Excellence on Natural Products for Neuroprotection and Anti-Ageing (Neur-Age NatChula), Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0003-4177-2165
Anchalee PrasansuklabCollege of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0001-8884-3077

Funding

Thailand Science Research and Innovation Fund, Chulalongkorn University Fundamental Fund
6 · The paper itself

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most prevalent neurodegenerative disorders, while the therapeutic efficacy of current drugs for both diseases remains limited, with unfavourable side effects. The fruit of

Indexed as

ArecaNeurodegenerative DiseasesNeuroprotective AgentsPlant ExtractsAlzheimer DiseaseAnimalsCaenorhabditis elegansHumansMiceMicrogliaMolecular Docking SimulationNetwork PharmacologyNeuroprotective AgentsPlant ExtractsAlzheimer’s diseaseareca nutCaenorhabditis elegansmicroglianeuroinflammationParkinson’s diseasetherapeutic mechanisms

Identifiers

PMID42352894
PMCPMC13300171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.